相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
Matteo Ferro et al.
WORLD JOURNAL OF UROLOGY (2019)
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Alessia Cimadamore et al.
CURRENT DRUG METABOLISM (2019)
Overweight and obesity during adolescence increases the risk of renal cell carcinoma
Anna Landberg et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment
Roberto Tamma et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer
Mei Yi et al.
MOLECULAR METABOLISM (2019)
Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients
Giorgia Mandili et al.
BIOMARKERS (2018)
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity
Joshua D. Ochocki et al.
CELL METABOLISM (2018)
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
A patent review of IDO1 inhibitors for cancer
Jae Eun Cheong et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Metabolomics and Metabolic Reprogramming in Kidney Cancer
Robert H. Weiss
SEMINARS IN NEPHROLOGY (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J. Ricketts et al.
CELL REPORTS (2018)
The urea cycle enzymes act as metabolic suppressors in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
AGING-US (2018)
Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
Panagiotis Tsiakanikas et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
The emerging role of obesity, diet and lipid metabolism in prostate cancer
Matteo Ferro et al.
FUTURE ONCOLOGY (2017)
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
Massimo Papale et al.
ONCOTARGET (2017)
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation
Cristina Bianchi et al.
ONCOTARGET (2017)
The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy
Yaojie Fu et al.
ONCOTARGET (2017)
The Emerging Role of Histone Demethylases in Renal Cell Carcinoma
Xiaoqiang Guo et al.
JOURNAL OF KIDNEY CANCER AND VHL (2017)
Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging
Omran Abu Aboud et al.
CANCER RESEARCH (2017)
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
Kiril Trpkov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review
Giuseppe Di Lorenzo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Arginine dependence of tumor cells: targeting a chink in cancer's armor
M. D. Patil et al.
ONCOGENE (2016)
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
Caroline Jochems et al.
ONCOTARGET (2016)
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Josephine F. Trott et al.
ONCOTARGET (2016)
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth
Omran Abu Aboud et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
Margherita Gigante et al.
MEDICINE (2015)
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma
Giuseppe Lucarelli et al.
MEDICINE (2015)
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Emelyn H. Shroff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance
Ottavio de Cobelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
Giuseppe Lucarelli et al.
ONCOTARGET (2015)
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma A Prospective Cohort Study
Jeremiah J. Morrissey et al.
JAMA ONCOLOGY (2015)
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson et al.
MODERN PATHOLOGY (2015)
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
Alberto Breda et al.
WORLD JOURNAL OF UROLOGY (2015)
Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
Giuseppe Lucarelli et al.
DISEASE MARKERS (2014)
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
Antonio Vavallo et al.
MEDICINE (2014)
L-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Eun-Hee Shim et al.
CANCER DISCOVERY (2014)
In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
Paulo A. Gameiro et al.
CELL METABOLISM (2013)
Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma
Christina A. von Roemeling et al.
CLINICAL CANCER RESEARCH (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Inhibition of PPARα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells
Omran Abu Aboud et al.
PLOS ONE (2013)
α-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-γ activation and COX-2 inhibition
Lijun Yang et al.
ONCOLOGY LETTERS (2013)
Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism
Susana Ros et al.
CANCER & METABOLISM (2013)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Paolo Cirri et al.
CANCER AND METASTASIS REVIEWS (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Kidney Tumor Biomarkers Revealed by Simultaneous Multiple Matrix Metabolomics Analysis
Sheila Ganti et al.
CANCER RESEARCH (2012)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Urinary acylcarnitines are altered in human kidney cancer
Sheila Ganti et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
Martina Redova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer
Christopher J. Ricketts et al.
JOURNAL OF UROLOGY (2012)
Epigenetic regulation in RCC: opportunities for therapeutic intervention?
James Larkin et al.
NATURE REVIEWS UROLOGY (2012)
14-3-3 Protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid
Satoru Minamida et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
N. M. A. White et al.
BRITISH JOURNAL OF CANCER (2011)
Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I Activity
Daniel Tello et al.
CELL METABOLISM (2011)
PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine
Brian P. Lieberman et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma
Vladimir A. Valera et al.
JOURNAL OF CANCER (2011)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Xin Huang et al.
MOLECULAR CELL (2009)
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2008)
Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma
Akio Horiguchi et al.
JOURNAL OF UROLOGY (2008)
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism
Julian Aragones et al.
NATURE GENETICS (2008)
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Cheol-Yong Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Peroxisome proliferator-activated receptor-α and liver cancer:: where do we stand?
JM Peters et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
6-phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia
M Obach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells
EJ Noh et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tryptophan and the immune response
JR Moffett et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Peroxisome proliferator-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231
KM Suchanek et al.
MOLECULAR CARCINOGENESIS (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis
H Gong et al.
LEUKEMIA (2000)
分享论文
